Anemoside B4 Exerts Hypoglycemic Effect by Regulating the Expression of GLUT4 in HFD/STZ Rats
Molecules · 18.01.2023 · 28 (3) · 968
DOI: 10.3390/molecules28030968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 18.01.2023. Verfasst von Qin Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330006, China. Hauptthemen laut MEDLINE: Saponins, Hyperglycemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan of Jiangxi Provincial Health Commission.
Abstract (Originalsprache)
Anemoside B4 (B4) is a saponin that is extracted from Pulsatilla chinensis (Bge.), and Regel exhibited anti-inflammatory, antioxidant, antiviral, and immunomodulatory activities. However, its hypoglycemic activity in diabetes mellitus has not been evaluated. Here, we explored the effect of B4 on hyperglycemia and studied its underlying mechanism of lowering blood glucose based on hyperglycemic rats in vivo and L6 skeletal muscle cells (L6) in vitro. The rats were fed a high-fat diet (HFD) for one month, combined with an intraperitoneal injection of 60 mg/kg streptozotocin (STZ) to construct the animal model, and the drug was administrated for two weeks. Blood glucose was detected and the proteins and mRNA were expressed. Our study showed that B4 significantly diminished fasting blood glucose (FBG) and improved glucose metabolism. In addition, B4 facilitated glucose utilization in L6 cells. B4 could enhance the expression of glucose transporter 4 (GLUT4) in rat skeletal muscle and L6 cells. Mechanistically, B4 elevated the inhibition of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathways. Furthermore, we confirmed the effect of B4 on glucose uptake involved in the enhancement of GLUT4 expression in part due to PI3K/AKT signaling by using a small molecule inhibitor assay and constructing a GLUT4 promoter plasmid. Taken together, our study found that B4 ameliorates hyperglycemia through the PI3K/AKT pathway and promotes GLUT4 initiation, showing a new perspective of B4 as a potential agent against diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330006, China.
- National Engineering Research Center for Manufacturing Technology of Solid Preparation, Nanchang 330006, China.
- Institute of Traditional Chinese Medicine, Jiangsu Union Technical Institute Lianyungang Branch, Lianyungang 222007, China.
- School of Life Sciences, Tsinghua University, Beijing 100084, China.
ORCID-Profile: Qin Gong, Mulan Wang
Förderung
- Science and Technology Plan of Jiangxi Provincial Health Commission
Zitieren
APA
Gong, Q., Yin, J., Wang, M., Zha, C., Yu, D., Yang, S., Feng, Y., Li, J., & Du, L. (2023). Anemoside B4 Exerts Hypoglycemic Effect by Regulating the Expression of GLUT4 in HFD/STZ Rats. Molecules, 28(3), 968. https://doi.org/10.3390/molecules28030968
Vancouver
Gong Q, Yin J, Wang M, Zha C, Yu D, Yang S, et al. Anemoside B4 Exerts Hypoglycemic Effect by Regulating the Expression of GLUT4 in HFD/STZ Rats. Molecules. 2023;28(3):968. doi:10.3390/molecules28030968
BibTeX
@article{Gong2023,
author = {Gong, Qin and Yin, Jilei and Wang, Mulan and Zha, Chengliang and Yu, Dong and Yang, Shilin and Feng, Yulin and Li, Jun and Du, Lijun},
title = {Anemoside B4 Exerts Hypoglycemic Effect by Regulating the Expression of GLUT4 in HFD/STZ Rats},
journal = {Molecules},
year = {2023},
volume = {28},
number = {3},
pages = {968},
doi = {10.3390/molecules28030968}
}
EUVIMED